Elosulfase alfa for mucopolysaccharidosis type IVA: Real-world experience in 7 patients from the Spanish Morquio-A early access program

There is a growing interest in evaluating the effectiveness of enzyme replacement therapy (ERT) with elosulfase alfa in patients with mucopolysaccharidosis type IVA (MPS-IVA) under real-world conditions. We present the experience of seven pediatric MPS-IVA patients from the Spanish Morquio-A Early A...

Descripción completa

Detalles Bibliográficos
Autores principales: Pintos-Morell, Guillem, Blasco-Alonso, Javier, Couce, María L., Gutiérrez-Solana, Luís G., Guillén-Navarro, Encarna, O'Callaghan, Mar, del Toro, Mireia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047108/
https://www.ncbi.nlm.nih.gov/pubmed/30023300
http://dx.doi.org/10.1016/j.ymgmr.2018.03.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047108/
https://www.ncbi.nlm.nih.gov/pubmed/30023300
http://dx.doi.org/10.1016/j.ymgmr.2018.03.009

Ejemplares similares